Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Open-Angle Glaucoma (OAG) Market Size And Revenue Forecast Through 2030
The open-angle glaucoma (oag) sector experienced a robust expansion lately and is projected to continue this trajectory, expanding from $6.53 billion in 2025 to $6.96 billion in 2026 with a compound annual growth rate (CAGR) of 6.5%. This historical growth surge was fueled by several factors, including restricted availability of face-to-face mental health support, an increasing incidence of anxiety and depression, heightened recognition of mental well-being’s significance, the escalating adoption of telemedicine services, and the early integration of online therapy solutions.
The market for open-angle glaucoma (oag) is poised for substantial expansion in the coming years, projected to reach $8.86 billion by 2030 with a compound annual growth rate of 6.2%. This anticipated growth is fueled by several key factors including an escalating demand for telehealth services, wider acceptance of digital counseling platforms, the growing incorporation of artificial intelligence in mental well-being solutions, the increasing prevalence of blended therapy approaches that merge one-on-one and group sessions, and a broader availability of online therapeutic options across both commercial and residential sectors. Significant developments expected during this forecast period involve a greater uptake of prostaglandin analog medications, increased utilization of micro-invasive surgical procedures for glaucoma, enhanced public awareness concerning early detection and screening protocols, a rise in remote ophthalmology consultations for managing oag, and ongoing advancements in the creation of combined pharmaceutical treatments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp
Open-Angle Glaucoma (OAG) Market Development Factors: Which Trends Are Supporting Demand?
Increased consciousness regarding ocular ailments is anticipated to bolster the expansion of the open-angle glaucoma (OAG) market. Ocular conditions, which involve disorders affecting the physical integrity, performance, or visual capabilities of the eyes, span a spectrum from minor issues like dry eye to severe conditions such as glaucoma and macular degeneration. The increasing incidence of these conditions is linked to an aging global demographic, extended periods spent viewing digital screens, a rise in diabetes diagnoses, environmental contamination, and lifestyle choices detrimental to eye well-being. Open-angle glaucoma (OAG), a primary contributor to vision impairment, particularly in older individuals, highlights the imperative for regular eye examinations, prompt identification, and timely management to prevent permanent vision deterioration. Illustratively, in October 2023, the Royal National Institute of Blind People (RNIB) reported that UK outpatient appointments for eye care surpassed eight million during the 2021/22 period, establishing it as the foremost sought-after medical specialty. Furthermore, the existing population experiencing vision loss, already exceeding two million, is forecasted to double, reaching over four million by the year 2050. Consequently, heightened awareness surrounding eye diseases is fueling the expansion of the open-angle glaucoma (OAG) market.
Open-Angle Glaucoma (OAG) Market Segmentation Trends And Revenue Drivers
The open-angle glaucoma (oag) market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma
Open-Angle Glaucoma (OAG) Market Transformation Trends: Which Innovations Are Driving Change?
Within the open-angle glaucoma (OAG) sector, leading businesses are actively focusing on creating novel approaches, exemplified by the advancement of minimally invasive glaucoma devices (MIGDs), which serve as sophisticated, gentler options for addressing primary open-angle glaucoma and diminishing the need for established interventions. A minimally invasive glaucoma device (MIGD) encompasses a spectrum of surgical implants and procedures engineered to decrease intraocular pressure in individuals with glaucoma, employing tiny incisions and minimal disturbance to the eye’s delicate tissues. As an illustration, in December 2023, the Belgian medtech firm iSTAR Medical introduced MINIject to the Dutch market. This innovative bio-integrating therapeutic employs a distinctive porous STAR material, specifically designed to improve fluid drainage and thereby lower intraocular pressure. Consequently, by lessening the reliance on conventional treatments, MINIject signifies a pivotal progression in glaucoma management, presenting a more secure and efficacious strategy for handling this primary contributor to irreversible vision loss.
Open-Angle Glaucoma (OAG) Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.
Access The Complete Open-Angle Glaucoma (OAG) Market Report:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report
Open-Angle Glaucoma (OAG) Market Geographic Analysis: Where Is Demand Growing The Fastest?
North Americawas the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model